- Raymond James’ adjusted EPS for Q3 is $2.39, beating last year’s $1.85 and slightly exceeding the estimate of $2.34.
- The actual EPS is $2.31, up from $1.71 last year.
- Assets under administration have reached $1.48 trillion, marking a 16% increase from last year, and meeting the estimated amount of $1.48 trillion.
- Net revenue is $3.23 billion, reflecting an 11% increase from last year, just below the estimate of $3.24 billion.
- Investment banking revenues showed a slight increase from the previous quarter due to higher debt and equity underwriting revenues.
- Mergers and acquisitions (M&A) revenues have declined.
- Analyst recommendations include 7 buys, 11 holds, and 0 sells.
A look at Raymond James Financial Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 3 | |
| Dividend | 3 | |
| Growth | 4 | |
| Resilience | 5 | |
| Momentum | 3 | |
| OVERALL SMART SCORE | 3.6 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Raymond James Financial, a leading provider of financial services, seems to have a promising long-term outlook based on its Smartkarma Smart Scores. With a strong focus on growth and a high resilience rating, the company is positioned well to weather market fluctuations and capitalize on emerging opportunities. The firm’s solid overall performance in key areas such as resilience and growth bodes well for its future prospects.
Raymond James Financial, with its balanced scores across various factors including value, dividend, and momentum, presents a favorable investment opportunity for individuals, corporations, and municipalities seeking stability and potential growth in the financial services sector. The company’s widespread operations in the United States, Canada, and overseas further solidify its position as a reliable player in the industry, indicating a positive trajectory in the long run.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
